Research reveals that stimulating the inferior colliculus can improve mobility in Parkinson's disease patients, offering new therapeutic avenues.
Researchers are uncovering new methods to enhance mobility in Parkinson's disease patients by targeting specific brain regions with stimulation techniques. This study, conducted by teams from Ruhr University Bochum and Philipps-Universität Marburg in Germany, highlights the potential of deep brain stimulation to improve patients' quality of life. Their findings were published in the journal Scientific Reports on April 12, 2025.
As Parkinson's disease progresses, patients often face debilitating mobility issues. When medications no longer provide adequate relief, deep brain stimulation emerges as an alternative. This procedure involves implanting a pulse generator within the brain, with common targets including the subthalamic nucleus, part of the basal ganglia system.
Led by Dr. Liana Melo-Thomas, previous investigations by the Marburg team revealed that stimulation of the inferior colliculus—a region traditionally recognized for its role in auditory processing—can address mobility restrictions. According to Melo-Thomas, “There's evidence that stimulating this brain area activates the mesencephalic locomotor region (MLR), which is vital for gait.”
Notably, unlike the basal ganglia, the inferior colliculus remains unaffected by Parkinson's disease. The researchers found that activating this area can trigger alternative motor pathways to enhance mobility in patients. Their latest study sought to further explore this mechanism's positive impact on walking ability.
The Marburg group, alongside Dr. Wolfgang Kruse of Ruhr University Bochum's Department of General Zoology and Neurobiology, capitalized on advanced optogenetic techniques. The team, under Professor Stefan Herlitze's guidance in Bochum, took significant strides in developing this methodology, which allows targeted activation of specific neural circuits.
Through the use of optogenetics, the researchers engineered genetically modified animals that express light-sensitive proteins in strategically chosen brain regions. By deploying light through tiny optical fibers implanted in these areas, they could selectively activate or inhibit neuronal cells. This approach offers a heightened level of precision compared to traditional electrical stimulation, which tends to affect a broader region around the stimulation site.
For the first time, the impact of this localized stimulation was measured through electrophysiological recordings of neuronal activity in relevant brain structures. Utilizing a multi-electrode setup developed at Philipps-Universität Marburg, the team efficiently conducted simultaneous recordings with multiple electrodes, reducing the number of test subjects required. Behavioral changes induced by stimulation were monitored in awake, behaving animals, providing a robust data set.
Optimizing Mobility with Inferior Colliculus Stimulation
The optogenetic stimulation of the inferior colliculus resulted in a substantial increase in neuronal activity in the targeted area. “Simultaneous measurements in the deeper MLR showed heightened activity in most cells, although about 25% experienced inhibition due to the increased stimulation from the inferior colliculus,” Kruse reported. The activation of these neuronal cells was recorded with an impressive average latency of 4.7 milliseconds, underscoring a functional synaptic connection between the inferior colliculus and MLR.
Exploring neural circuits beyond the basal ganglia impacted by Parkinson's disease presents a promising direction for developing new treatments for motor deficits. The interactions between the inferior colliculus and MLR investigated in this study may contribute to this evolving understanding.
Kruse stated, “While the journey toward new therapies for Parkinson's symptoms may still be lengthy, foundational research like ours is critical.” The precise mechanisms behind the relief offered by traditional deep brain stimulation in the basal ganglia remain unclear, but continuing to investigate these additional pathways may yield new insights that enhance treatment strategies over time.
Materials provided by Ruhr-University Bochum. Original written by Meike Drießen. Note: Content may be edited for style and length.
New Fat-Dissolving Shot Cuts Hidden Visceral Fat in Early Human Trials
Aging Cells May Be Hiding From the Immune System – Scientists Think They Know How
Study Finds Exercise May Be a Surprisingly Powerful Treatment for Pain
Scientists Discover “Pac-Man Enzyme” That Eats Plastic
Stay informed with ScienceDaily's free email newsletter, updated daily and weekly. Or view our many newsfeeds in your RSS reader:
Keep up to date with the latest news from ScienceDaily via social networks:
Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Discussion
Sign in to join the discussion.